What is the most recent earnings date for WHWK stock?
WHITEHAWK THERAPEUTICS INC (WHWK) last reported earnings on 3/12/2026.
NASDAQ:WHWK • US00032Q1040
Past quarterly earnings results for WHITEHAWK THERAPEUTICS INC (WHWK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.34 | -0.16 | -116.45% | 49.25% | 20.4M | -100.00% | -100.00% | |
| Q3 2025 | -0.26 | 0.07 | -482.33% | 43.48% | 34M | -100.00% | -100.00% | |
| Q2 2025 | -0.76 | 0.50 | -251.03% | -40.74% | 34M | -100.00% | -100.00% | |
| Q1 2025 | -0.37 | -0.47 | 21.14% | 45.59% | 7.145M | - | 33.48% | |
| Q4 2024 | -0.67 | -0.22 | -198.57% | -11.67% | 7.239M | 7.599M | -4.74% | 14.43% |
| Q3 2024 | -0.46 | -0.47 | 1.43% | 23.33% | 7.212M | 6.728M | 7.19% | 21.01% |
| Q2 2024 | -0.54 | -0.70 | 23.27% | 19.40% | 6.179M | 6.321M | -2.25% | -0.34% |
| Q1 2024 | -0.68 | -0.66 | -3.76% | -19.30% | 5.353M | 6.583M | -18.68% | -8.81% |
| Q4 2023 | -0.60 | -0.66 | 9.22% | -15.38% | 6.326M | 6.418M | -1.43% | 20.96% |
| Q3 2023 | -0.60 | -0.74 | 18.75% | 11.76% | 5.96M | 6.745M | -11.64% | 40.24% |
| Q2 2023 | -0.67 | -0.63 | -5.60% | 22.99% | 6.2M | 6.325M | -1.98% | 80.23% |
| Q1 2023 | -0.57 | -0.60 | 4.31% | 13.64% | 5.87M | 5.59M | 5.01% | 154.11% |
| Q4 2022 | -0.52 | -0.72 | 28.20% | 32.47% | 5.23M | 4.743M | 10.27% | 423.00% |
| Q3 2022 | -0.68 | -0.76 | 10.15% | 50.00% | 4.25M | 3.846M | 10.50% | - |
| Q2 2022 | -0.87 | -0.77 | -13.73% | 35.56% | 3.44M | 2.808M | 22.51% | 2,766.67% |
| Q1 2022 | -0.66 | -0.73 | 9.12% | 51.11% | 2.31M | 511.02K | 352.04% | - |
| Q4 2021 | -0.77 | -1.00 | 23.13% | 48.67% | 1M | 45.9K | 2,078.65% | - |
| Q3 2021 | -1.36 | -0.68 | -101.01% | 24.44% | 66.3K | -100.00% | -100.00% | |
| Q2 2021 | -1.35 | -6.12 | 77.94% | - | 120K | - | -40.00% | |
| Q1 2021 | -1.35 | -1.38 | 1.96% | - | - | - | ||
| Q4 2020 | -1.50 | -2.07 | 27.38% | - | - | - | ||
| Q3 2020 | -1.80 | -2.14 | 15.97% | - | 230K | - | - | |
| Q2 2020 | - | - | 200K | - | - | |||
| Q1 2020 | - | - | - | - |
Notes
WHITEHAWK THERAPEUTICS INC (WHWK) last reported earnings on 3/12/2026.
WHITEHAWK THERAPEUTICS INC (WHWK) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, WHITEHAWK THERAPEUTICS INC (WHWK) has beaten EPS estimates in 1 out of 4 releases.